Montelukast sodium statistically elevatesthe serum level of anti-inflammatory protein IL-10 and reduces peripheral bloodeosinophils following a 4-week treatment, providing clinical benefits for childrenwith chronic asthma (28). This evidence concerns the gene IL10 and chronic asthma.